Status:
UNKNOWN
Haemodynamics of Mitral Regurgitation Reduction
Lead Sponsor:
Guy's and St Thomas' NHS Foundation Trust
Collaborating Sponsors:
King's College Hospital NHS Trust
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Mitral Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
There is uncertainty in terms of the superiority of conventional valve surgery or percutaneous transcatheter intervention for the treatment of severe mitral regurgitation (MR) in high risk patients. T...
Detailed Description
Conventional surgery for mitral regurgitation (MR) in high risk patients is associated with reduced benefit and increased risk of perioperative complications.Percutaneous transcatheter intervention (e...
Eligibility Criteria
Inclusion
- Severe mitral regurgitation as per European Society of Cardiology guidelines
- Patients undergoing MVRR or TMVI as standard of care
- Patients at high, prohibitive surgical risk as judged by the Heart Team
Exclusion
- Pregnancy and patients under the age of 18 years
- Congenital heart disease
- Moderate or severe mitral stenosis, aortic, pulmonary valve disease
- Patients currently enrolled in any other study where involvement in this study would involve deviation from either protocol
Key Trial Info
Start Date :
June 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 6 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05403840
Start Date
June 6 2022
End Date
January 6 2025
Last Update
June 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.